Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
Pfizer, a member of Bio Nebraska, and BioNTech announced that their vaccine candidate has been found to be over 90 percent effective against COVID-19. Read more